Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents

References

• Avendano C, Menendez JC. Medicinal chemistry of anticancer drugs. 1st ed. Chapter 1. Amsterdam: Elsevier; 2008.
   Google Scholar
• Szakacs G, Ludwig JA, Booth-Genthe C, et al. Targeting multidrug resistance in cancer. Nat Rev Drug Disc 2006;5:219–34.
   PubMed Web of Science ®Google Scholar
• Kathawala RJ, Gupta P, Ashby Jr CR, et al. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug Resist Update 2015;18:1–7.
   PubMed Web of Science ®Google Scholar
• Kidwai M, Jahan A, Mishra NK. Isatins: a diversity orientated biological profile. Med Chem 2014;4:451–68.
   Google Scholar
• Al-Wabli RI, Zakaria AS, Attia MI. Synthesis, spectroscopic characterization and antimicrobial potential of certain new isatin-indole molecular hybrids. Molecules 2017;22:1958.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Al-Ansary GH, Bua S, et al. Novel indolin-2-onebased sulfonamides as carbonic anhydrase inhibitors: synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies. Eur J Med Chem 2017;127:521–30.
   PubMed Web of Science ®Google Scholar
• Sridhar SK, Ramesh A. Synthesis and pharmacological activities of hydrazones, Schiff and Mannich bases of isatin derivatives. Biol Pharm Bull 2001; 24:1149–52.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Abdel-Aziz MM, et al. Design, synthesis and antitubercular activity of certain nicotinic Acid hydrazides. Molecules 2015;20:8800–15.
   PubMed Web of Science ®Google Scholar
• Dhillon S. Nintedanib: a review of its use as second-line treatment in adults with advanced non-small cell lung cancer of adenocarcinoma histology. Target Oncol 2015;10:303–10.
   PubMed Web of Science ®Google Scholar
• Rossi A, Latiano TP, Parente P, et al. The potential role of nintedanib in treating colorectal cancer. Expert Opin Pharmacother 2017;18:1153–62.
   PubMed Web of Science ®Google Scholar
• Cutsem EV, Yoshino T, Hocke J, et al. Rationale and design for the LUME-Colon 1 Study: a randomized, double-blind, placebo-controlled phase III trial of nintedanib plus best supportive care versus placebo plus best supportive care in patients with advanced colorectal cancer refractory to standard treatment. Clin Colorectal Cancer 2016;15:91–4.
   PubMed Web of Science ®Google Scholar
• Quintela-Fandino M, Urruticoechea A, Guerra J, et al. Phase I clinical trial of nintedanib plus paclitaxel in early HER-2-negative breast cancer (CNIO-BR-01-2010/GEICAM-2010-10 study). Br J Cancer 2014;111:1060–4.
   PubMed Web of Science ®Google Scholar
• Goodman VL, Rock EP, Dagher R, et al. Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. Clin Cancer Res 2007;13:1367–73.
   PubMed Web of Science ®Google Scholar
• Attia MI, Eldehna WM, Afifi SA, et al. New hydrazonoindolin-2-ones: synthesis, exploration of the possible anti-proliferative mechanism of action and encapsulation into PLGA microspheres. PLoS One 2017;12:e0181241.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz HA, Eldehna WM, Keeton AB, et al. Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling. Drug Des Devel Ther 2017;11:2333.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Almahli H, Al-Ansary GH, et al. Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents. J Enz Inhib Med Chem 2017;32:600–13.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ceruso M, et al. Amido/ureidosubstituted benzenesulfonamides-isatin conjugates as low nanomolar/subnanomolar inhibitors of the tumor-associated carbonic anhydrase isoform XII. Eur J Med Chem 2016;110:259–66.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ibrahim HS, et al. Synthesis and cytotoxic activity of biphenylurea derivatives containing indolin-2-one moieties. Molecules 2016;21:762.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Altoukhy A, Mahrous H, et al. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. Eur J Med Chem 2015;90:684–94.
   PubMed Web of Science ®Google Scholar
• Fares M, Eldehna WM, Abou-Seri SM, et al. Design, synthesis and in vitro antiproliferative activity of novel isatin–quinazoline hybrids. Arch Der Pharm 2015;348:144–54.
   PubMed Web of Science ®Google Scholar
• Eldehna WM, Fares M, Ibrahim HS, et al. Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: synthesis, in vitro biological evaluation and molecular docking. Eur J Med Chem 2015;100:89–97.
   PubMed Web of Science ®Google Scholar
• (a) Eldehna WM, EL-Naggar DH, Hamed AR, et al. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells. J EnzInhib Med Chem 2018;33:309–18; (b) Eldehna WM, Abo-Ashour MF, Ibrahim HS, et al. Novel [(3-indolylmethylene)hydrazono]indolin-2-ones as apoptotic anti-proliferative agents: design, synthesis and in vitro biological evaluation. J Enz Inhib Med Chem 2018;33:686–700; (c) Abdel-Aziz HA, Eldehna WM, Hamed AR, et al. Synthesis, crystal structure, and biological activity of cis/trans amide rotomers of (Z)-N′-(2-oxoindolin-3-ylidene)formohydrazide. J Chem 2014;2014:760434.
   PubMed Web of Science ®Google Scholar
• Gabr MT, El-Gohary NS, El-Bendary ER, et al. Isatin-β-thiocarbohydrazones: microwave-assisted synthesis, antitumor activity and structure-activity relationship. Eur J Med Chem 2017;128:36–44.
   PubMed Web of Science ®Google Scholar
• Kondratieva ML, Pepeleva AV, Belskaia NP, et al. A new synthetic method for the 2H-[1, 2, 3]thiadiazolo [5, 4-b]indoles. Tetrahedron 2007;63:3042–8.
   Web of Science ®Google Scholar
• Dahiya R, Narayan S, Bindal V, et al. Heterocyclic systems containing bridgehead nitrogen atom. Part 60. Synthesis of thiazolo[2′, 3′: 3, 4][1, 2, 4]triazino[5, 6‐b]indoles. Indian J Chem Sect B 1987;26B:535–8.
   Google Scholar
• Pal R, Jain K, Gupta G, et al. Heterocyclic systems containing bridgehead nitrogen atom. lxxii: reaction of 5H-2,3-dihydro-[1, 2, 4]triazino[5, 6-b]indole-3-thiones with phenacyl bromide, 1, 2-dibromoethane and chloroacetic acid. Indian J Chem Sect B 1991;30B:1098–103.
   Google Scholar
• Mohan J, Anjaneyulu G, Kiran K. Heterocyclic systems containing bridgehead nitrogen atom: Synthesis of thiazolo [3′, 2′: 2, 3][1, 2, 4]triazino [5, 6‐b]indoles and isomeric thiazolo [2′, 3′: 3, 4][1, 2, 4]triazino[5, 6‐b]indoles. Indian J Chem Sect B 1988;27B:346–9.
   Google Scholar
• Xie Z, Wang G, Wang J, et al. Synthesis, biological evaluation, and molecular docking studies of novel isatin-thiazole derivatives as α-glucosidase inhibitors. Molecules 2017; 22:659.
   PubMed Web of Science ®Google Scholar
• Meleddu R, Distinto S, Corona A, et al. (3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase. Eur J Med Chem 2015;93:452–60.
   PubMed Web of Science ®Google Scholar
• Hannah R, Beck M, Moravec R, et al. CellTiter-Glo™ Luminescent cell viability assay: a sensitive and rapid method for determining cell viability. Promega Cell Notes 2001;2:11–13.
   Google Scholar
• Collins K, Jacks T, Pavletich NP. The cell cycle and cancer. Proc Natl Acad Sci USA 1997;94:2776–8.
   PubMed Web of Science ®Google Scholar
• De Falco M, De Luca A. Cell cycle as a target of antineoplastic drugs. Curr Pharm Des 2010; 16:1417–26.
   PubMed Web of Science ®Google Scholar
• Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995;81:323–30.
   PubMed Web of Science ®Google Scholar
• Woitach JT, Zhang M, Niu C-H, et al. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Nat Genet 1998;19:371.
   PubMed Web of Science ®Google Scholar
• Soule HD, Maloney TM, Wolman SR, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990;50:6075–86.
   PubMed Web of Science ®Google Scholar
• Quaroni A, Wands J, Trelstad RL, et al. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J Cell Biol 1979;80:248–65.
   PubMed Web of Science ®Google Scholar
• Todaro GJ, Green H. Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J Cell Biol 1963;17:299–13.
   PubMed Web of Science ®Google Scholar